08.18.26 -- Ensuring Successful Technology Transfer In ADC Development

Examine the challenges when moving a bioconjugate candidate from early development to clinic, along with integrated solutions for navigating this growing area of the biopharmaceutical industry.

The production of viral vectors depends on the development of master virus seed stocks. Learn more about two cases where clients were enabled to overcome obstacles during virus bank manufacturing.

Choosing licensed vs. unlicensed cell lines impacts development speed, cost, flexibility, and long‑term control, making early strategic evaluation key to efficient biologics development.

Technology transfer succeeds through trust, shared knowledge, and disciplined execution. Delve into how collaboration, strong documentation, and digital tools reduce risk on the path to GMP.

Through early collaboration and advanced aseptic technology, organizations can overcome complex formulation challenges to ensure safe, effective treatments reach patients more efficiently than before.

Advances in genome engineering and immune evasion are enabling scalable, durable allogeneic cell therapies, overcoming rejection challenges and expanding potential treatments across diverse diseases.

Explore the benefits of using mRNA for vaccines and therapeutics, and learn how to address technical, intellectual property, and cost considerations when considering commercial production.

ADC developability assessment catches safety, functionality, and manufacturability liabilities before CMC — reducing costly late-stage failures. See the assay framework in action.

Meet us at CPHI Worldwide in Milan to gain insight into solutions for late-stage drug product development, manufacturing readiness, and CMC support.

Discover how effective technology transfer strategies can streamline scale-up, maintain product quality, and enable successful clinical and commercial manufacturing.

Modernize quality control by integrating automated workflows, digital records, and advanced training. Eliminating paper protects data integrity and accelerates regulatory timelines.